Senate bill · 119th Congress · Latest step: Introduced
A bill to amend the Public Health Service Act to streamline the review of biosimilar biological products.
Sponsor: Sen. Ashley Moody R-FLWhere it went
- IntroducedJul 21, 2026
- Committee action—
- Passed Senate—
- Passed House—
- To the President—
- Became law—
Latest action: Jul 21, 2026 — Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Vote results
No recorded roll-call votes on this bill in PORKER’s records (voice votes and unanimous consent are not roll calls; roll-call records start in 2011).
Cosponsors
3 cosponsors — 1 Republican, 2 Democrats
2 of 3 cosponsors (67%) are from the other party.
Angela Alsobrooks (D-MD), Lisa Blunt Rochester (D-DE), Rick Scott (R-FL).
More from the sponsor
Other 119th Congress bills sponsored by Sen. Ashley Moody.
- S.Res. 233 (119th) A resolution commending and congratulating the University of Florida men's basketball team for winning the 2025 National Collegiate…
- S.Res. 333 (119th) A resolution commending and congratulating the Florida Panthers on winning the 2025 Stanley Cup Final.
- S.Res. 871 (119th) A resolution supporting the goals and ideals of National Purple Heart Recognition Day.
- S.Res. 925 (119th) A resolution designating September 2026 as "National Spinal Cord Injury Awareness Month"
- S. 1782 (119th) Charlotte Woodward Organ Transplant Discrimination Prevention Act
- S. 1809 (119th) Drone Espionage Act
Sponsor’s state and district
Data as of Sep 25, 2026 · bill record checked by PORKER from Congress.gov · votes from Senate.gov and the House Clerk. PORKER is non-partisan.